Jenny Leeds, Ph.D.

Vice President
8 years industry experience

Biography

Jenny Leeds is an investor for Counterpoint Global. She joined Morgan Stanley in 2019 and has eight years of investment experience. Prior to joining the firm, she was an associate and Equity Research Analyst at Bank of America Merrill Lynch (BAML) focused on biotechnology. Jenny received a Ph.D. in cancer biology and immunology from Memorial Sloan Kettering Cancer Center and a B.S. in biochemistry from Tufts University.

Jenny is a member of
Counterpoint Global

View Team

Strategies

Strategy Name	Description
Vitality	Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.

Vitality

Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.